T1	Participants 460 594	cured patients taking 750 mg mefloquine, peak plasma drug concentration (Cmax) and area under the plasma concentration-time curve (AUC
T2	Participants 171 248	clinical trial in Thailand among patients with malaria and healthy volunteers
